Trials / Not Yet Recruiting
Not Yet RecruitingNCT07122492
A Targeted Electronic Health Approach to Reduce Fear of Recurrence in Breast Cancer Survivors (FoRtitude)
Randomized Controlled Trial of FoRtitude: Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer Survivors in Community Oncology Settings
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 800 (estimated)
- Sponsor
- Eastern Cooperative Oncology Group · Network
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to determine if the intervention or if general information about being a breast cancer survivor can help Breast Cancer Survivors reduce their fear of recurrence. The main question it aims to answer are: Can the FoRtitude intervention lower the fear of recurrence for Breast Cancer Survivors? Participants will: Answer questions about their fear of recurrence. Be randomized to 1 of the 3 following options: (1) a weblink to access an eHealth intervention which includes a website and an optional interactive text-messaging feature, (2) a weblink to a non-interactive website that will include links to external websites with general information that may be helpful for Breast Cancer Survivors, or (3) you will need to talk with your oncology team about your concerns about recurrence or seek psychosocial care in the community. Be asked to fill out questionnaires 5 times for up to 18 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | FoRtitude 2.0 | A website and an interactive text-messaging feature |
| BEHAVIORAL | Attention Control | Access to the non-interactive study intervention website that lists links to help you access websites that provide information to read and resources for breast cancer survivors. |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2028-09-01
- Completion
- 2029-09-01
- First posted
- 2025-08-14
- Last updated
- 2025-08-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07122492. Inclusion in this directory is not an endorsement.